Multicentre observational screening survey for the detection of CTEPH following pulmonary embolism.

Coquoz, Nicolas; Weilenmann, Daniel; Stolz, Daiana; Popov, Vladimir; Azzola, Andrea; Fellrath, Jean-Marc; Stricker, Hans; Pagnamenta, Alberto; Ott, Sebastian; Ulrich, Silvia; Györik, Sandor; Pasquier, Jérôme; Aubert, John-David (2018). Multicentre observational screening survey for the detection of CTEPH following pulmonary embolism. European respiratory journal, 51(4) European Respiratory Society 10.1183/13993003.02505-2017

Text 1702505.full.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (444kB) | Request a copy

Chronic thromboembolic pulmonary hypertension (CTEPH) is a severe complication of pulmonary embolism. Its incidence following pulmonary embolism is debated. Active screening for CTEPH in patients with acute pulmonary embolism is yet to be recommended.This prospective, multicentre, observational study (Multicentre Observational Screening Survey for the Detection of Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Following Pulmonary Embolism (INPUT on PE); ISRCTN61417303) included patients with acute pulmonary embolism from 11 centres in Switzerland from March 2009 to November 2016. Screening for possible CTEPH was performed at 6, 12 and 24 months using a stepwise algorithm that included a dyspnoea phone-based survey, transthoracic echocardiography, right heart catheterisation and radiological confirmation of CTEPH.Out of 1699 patients with pulmonary embolism, 508 patients were assessed for CTEPH screening over 2 years. CTEPH incidence following pulmonary embolism was 3.7 per 1000 patient-years, with a 2-year cumulative incidence of 0.79%. The Swiss pulmonary hypertension registry consulted in December 2016 did not report additional CTEPH cases in these patients. The survey yielded 100% sensitivity and 81.6% specificity. The second step echocardiography in newly dyspnoeic patients showed a negative predictive value of 100%.CTEPH is a rare but treatable disease. A simple and sensitive way for CTEPH screening in patients with acute pulmonary embolism is recommended.

Interest & Impact

Downloads

1 since deposited on 21 Jan 2019
0 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item